Cargando…

Impact of Bevacizumab on parenchymal damage and functional recovery of the liver in patients with colorectal liver metastases

BACKGROUND: Little is known about the safety of the anti-VEGF antibody bevacizumab in patients undergoing resection for colorectal liver metastases (CLM). This meta-analysis evaluates the impact of bevacizumab on parenchymal damage and functional recovery in patients undergoing resection for CLM. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Volk, Andreas M., Fritzmann, Johannes, Reissfelder, Christoph, Weber, Georg F., Weitz, Jürgen, Rahbari, Nuh N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4750178/ https://www.ncbi.nlm.nih.gov/pubmed/26864935 http://dx.doi.org/10.1186/s12885-016-2095-6

Ejemplares similares

Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy
por: Rahbari, Nuh N, et al.
Publicado: (2014)

A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival
por: Pecqueux, Mathieu, et al.
Publicado: (2016)

A randomized controlled trial to investigate the influence of low dose radiotherapy on immune stimulatory effects in liver metastases of colorectal cancer
por: Reissfelder, Christoph, et al.
Publicado: (2011)

First application of intraoperative MRI of the liver during ALPPS procedure for colorectal liver metastases
por: Riediger, Carina, et al.
Publicado: (2020)

Prognostic value of circulating endothelial cells in metastatic colorectal cancer
por: Rahbari, Nuh N, et al.
Publicado: (2017)

Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer
por: Schölch, Sebastian, et al.
Publicado: (2019)

Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer
por: Lerbs, Tristan, et al.
Publicado: (2017)

Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis
por: Pecqueux, Mathieu, et al.
Publicado: (2015)

Infrahepatic Inferior Vena Cava Clamping does not Increase the Risk of Pulmonary Embolism Following Hepatic Resection
por: Birgin, Emrullah, et al.
Publicado: (2021)

Influence of two different resection techniques (conventional liver resection versus anterior approach) of liver metastases from colorectal cancer on hematogenous tumor cell dissemination – prospective randomized multicenter trial
por: Schmidt, T, et al.
Publicado: (2008)

Laparoscopic Infrahepatic Inferior Vena Cava Clamping During Liver Resection — a Feasibility Study
por: Téoule, Patrick, et al.
Publicado: (2023)

Remote Ischemic Preconditioning in a Cirrhotic Patient Undergoing Major Hepatectomy
por: Birgin, Emrullah, et al.
Publicado: (2020)

Minimally invasive mesohepatectomy for centrally located liver lesions—a case series
por: Birgin, Emrullah, et al.
Publicado: (2022)

A randomised controlled trial to evaluate and optimize the use of antiplatelet agents in the perioperative management in patients undergoing general and abdominal surgery- the APAP trial (ISRCTN45810007)
por: Antolovic, Dalibor, et al.
Publicado: (2011)

Combined Ablation and Resection (CARe) as an Effective Parenchymal Sparing Treatment for Extensive Colorectal Liver Metastases
por: Evrard, Serge, et al.
Publicado: (2014)

Colorectal cancer liver metastases within the central and peripheral segments: Parenchymal sparing surgery adaptation
por: Burlaka, A.A., et al.
Publicado: (2020)

Simultaneous colorectal and parenchymal-sparing liver resection for advanced colorectal carcinoma with synchronous liver metastases: Between conventional and mini-invasive approaches
por: De Raffele, Emilio, et al.
Publicado: (2020)

Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases
por: Fiorentini, Giammaria, et al.
Publicado: (2021)

LDB1 overexpression is a negative prognostic factor in colorectal cancer
por: García, Sebastián A., et al.
Publicado: (2016)

Contralateral Liver Hypertrophy and Oncological Outcome Following Radioembolization with (90)Y-Microspheres: A Systematic Review
por: Birgin, Emrullah, et al.
Publicado: (2020)

Parenchymal‐sparing versus extended hepatectomy for colorectal liver metastases: A systematic review and meta‐analysis
por: Deng, Gang, et al.
Publicado: (2019)

Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection
por: Yang, Cui, et al.
Publicado: (2017)

IVC CLAMP: infrahepatic inferior vena cava clamping during hepatectomy - a randomised controlled trial in an interdisciplinary setting
por: Rahbari, Nuh N, et al.
Publicado: (2009)

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy
por: Detsky, Jay S., et al.
Publicado: (2018)

Primary choriocarcinoma of the liver: a rare, but important differential diagnosis of liver lesions
por: Kohler, Alexander, et al.
Publicado: (2018)

Primary choriocarcinoma of the liver: a rare, but important differential diagnosis of liver lesions
por: Kohler, Alexander, et al.
Publicado: (2018)

Interrupted versus continuous suture technique for biliary-enteric anastomosis: randomized clinical trial
por: Seifert, Lena, et al.
Publicado: (2023)

Parenchymal Cell Damage and Bile Duct Activity in the Precancerous Liver
por: Sutton, P. M.
Publicado: (1962)

Parenchymal-sparing hepatectomy for multiple bilobar colorectal liver metastases in a Jehovah’s witness: a case report
por: Ratnayake, Shehan, et al.
Publicado: (2023)

FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer
por: Bertolini, F, et al.
Publicado: (2011)

FOLFOXIRI plus bevacizumab in the treatment of metastatic colorectal cancer patients with unresectable liver metastases
por: Antoniotti, Carlotta, et al.
Publicado: (2022)

Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer
por: Schölch, Sebastian, et al.
Publicado: (2016)

Management of Anastomotic Leakage after Colorectal Resection: Survey among the German CHIR-Net Centers
por: Șandra-Petrescu, Flavius, et al.
Publicado: (2023)

Clinical outcomes of parenchymal-sparing versus anatomic resection for colorectal liver metastases: a systematic review and meta-analysis
por: Wang, Kun, et al.
Publicado: (2023)

Comprehensive proteomic profiling of serum extracellular vesicles in patients with colorectal liver metastases identifies a signature for non-invasive risk stratification and early-response evaluation
por: Lin, Kuailu, et al.
Publicado: (2022)

Analysis of Inflammation-Related Genes in Patients with Stanford Type A Aortic Dissection
por: Li, Lin, et al.
Publicado: (2023)

Heterogeneous detection of circulating tumor cells in patients with colorectal cancer by immunomagnetic enrichment using different EpCAM-specific antibodies
por: Antolovic, Dalibor, et al.
Publicado: (2010)

Pelvic exenteration for colorectal and non-colorectal cancer: a comparison of perioperative and oncological outcome
por: Bogner, Andreas, et al.
Publicado: (2021)

Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab
por: Loupakis, F, et al.
Publicado: (2013)

Liver resection for non-colorectal metastases
por: Schwarz, Christoph, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1ik4gbrqcnd912jopq3tv6k01t